-
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share. The Company has now repurchased a…
-
The Silent Sleep Crisis: Apollo Experts Warn That 80-90% of Sleep Apnoea Cases Go Undiagnosed
Apollo Hospitals Navi Mumbai urges citizens not to ignore loud snoring and excessive daytime sleepiness as it launches a dedicated Sleep Disorders Clinic NAVI MUMBAI, India, July 16, 2026 /PRNewswire/ — Sleep disorders are emerging as one of the most overlooked public health concerns in the Mumbai Metropolitan Region (MMR), with experts estimating that nearly…
-
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to support research and development (R&D) while strengthening collaboration and customer engagement. The…
-
Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research
Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response MORRISVILLE, N.C., July 15, 2026 /PRNewswire/ — Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, today announced an expansion of…
-
Spire Healthcare announced as exclusive Team GB Official Healthcare Services Partner
Organisations join forces for “a healthier, more productive nation” Agreement with Team GB covers the Los Angeles 2028 Olympic Games LONDON, July 15, 2026 (GLOBE NEWSWIRE) — Spire Healthcare today announces a new strategic partnership with Team GB, becoming the team’s exclusive Official Healthcare Services Partner through to the end of 2028, including the Los…
-
NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists’ Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
WASHINGTON, July 14, 2026 /PRNewswire/ — On July 14, 2026, the U.S. Fish and Wildlife Service (“USFWS”) for the second time declined to accept a petition filed by People for the Ethical Treatment of Animals (“PETA”) and other activist groups to list long-tailed macaque (“LTM”) monkeys (Macaca fascicularis) under the U.S. Endangered Species Act (“ESA”). The…
-
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
July 13, 2026 20:35 ET | Source: Mesoblast Limited NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in the MSB-DR004 pivotal Phase 3 randomized controlled trial of rexlemestrocel-L…
-
IMG Opens Applications for 2026 Fall Semester ‘Student Journey Scholarship’
INDIANAPOLIS, July 13, 2026 /PRNewswire/ — IMG (International Medical Group) is now accepting applications for its Student Journey Scholarship, a program designed to help international students fund their studies at a U.S. college or university. Entries for the 2026 Fall semester will be accepted July 13-October 4, 2026, and one student will be selected to…
-
LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026
New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners July 12, 2026 11:18 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., July 12, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that new data…
-
FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2026
FORMER ELITE SOCCER PLAYERS SHOWEVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFE Key Takeaways New research provides insights into brain health among former elite professional soccer players during midlife. Former players reported high levels of depression, anxiety, and subjective difficulties with thinking and decision-making. Researchers found brain differences that warrant further study. The findings highlight the…
-
GuideAI Health Announces Marketing and Communications Programs
July 10, 2026 17:01 ET | Source: GuideAI Health Corp. BOSTON, July 10, 2026 (GLOBE NEWSWIRE) — GuideAI Health Corp. (Cboe CA: GDAI) (“GuideAI” or the “Company“) is pleased to announce that it has engaged Upswitch Media Corp. (“Upswitch”) and BTV-Business Television (“BTV”) — to execute a coordinated marketing, communications and investor-awareness program (the “Program”). The…
-
Horse Boost Gummies For Men 2026 Launch Featuring the Viral Horse Gelatin Salt Trick Recipe Male Enhancement Support By HorseBoost
New York City, July 11, 2026 (GLOBE NEWSWIRE) — In 2026, Horse Boost announces a new Gummies formula that takes a science-inspired approach to male health performance by focusing on a thoughtfully developed combination of ingredients commonly used in dietary supplements for supporting energy, vitality, stamina, circulation, stress management, and performance well-being. The formulation reflects…
-
Happiest Health Announces Launch of Speciality Clinics: Happiest Paediatrics, Happiest Orthopaedics, Happiest Gynaecology, Happiest Endocrinology & Your Personal Physician
BENGALURU, India, July 9, 2026 /PRNewswire/ — Happiest Health is happy to announce the launch of Speciality Clinics, Happiest Paediatrics, Happiest Orthopaedics, Happiest Gynaecology, Happiest Endocrinology & Your Personal Physician in Koramangala, Bengaluru, marking its entry into neighbourhood healthcare. This represents a significant expansion of the company’s healthcare ecosystem, bringing consultations, diagnostics, and pharmacy services together…
-
Canadian Red Cross opens appeal to support people impacted by flooding in Manitoba
WINNIPEG, Manitoba, July 10, 2026 (GLOBE NEWSWIRE) — The Canadian Red Cross has launched the 2026 Manitoba Floods Appeal to provide support for those impacted by flooding in Manitoba. Donations to the Canadian Red Cross will be used to provide assistance to those impacted by the flooding in Manitoba with immediate and ongoing relief, recovery, and…
-
Garware Fulflex Completes Acquisition of 300,000-Square-Foot Fully Automated Medical Products Manufacturing Facility in The United States
PUNE, India and JACKSONVILLE, Texas, July 10, 2026 /PRNewswire/ — Garware Fulflex today announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facility in Jacksonville, Texas, marking a major milestone in the company’s global healthcare growth strategy and significantly expanding its manufacturing footprint in North America. Situated on a…
-
No easy answers: European research consortia take on major challenges
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) — Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological systems. With a European expansion, the 2026 awards unite strong research groups and diverse expertise across Europe in the pursuit of novel knowledge…
-
Guwahati Gets a Life-Saving Heart Breakthrough: Apollo Hospitals Performs Northeast India’s First LAA Closure
Recognised as one of the Best Cardiology Hospitals in Guwahati, Apollo’s expert team brings new hope to patients who cannot safely take blood-thinning medicines GUWAHATI, India, July 9, 2026 /PRNewswire/ — A silent but life-saving battle was won recently in Guwahati. Doctors at Apollo Hospitals Guwahati – widely regarded as the Best Hospital in Guwahati for…
-
NTG Nordic Transport Group A/S – H1 2026 Conference Call
July 09, 2026 04:00 ET | Source: NTG Nordic Transport Group A/S NTG Nordic Transport Group A/S – H1 2026 Conference Call We expect to release the H1 2026 interim results of NTG Nordic Transport Group on the evening of August 10, 2026. A webcast and conference call will be held in the morning of…
-
Star Health’s Arogya Seva Kendras support over 6,830 beneficiary visits across Punjab, bringing free primary healthcare closer to communities
Star Health currently operates three Arogya Seva Kendras in Punjab across Amritsar, Bhatinda and Patiala Launched in January 2026, the three centres together have supported over 6,830 beneficiary visits Diabetes, fever, hypertension and respiratory illnesses are among the common cases seen at the centres, underlining the need for accessible neighbourhood-level healthcare PATIALA, India, July 9, 2026…
-
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
Proposed acquisition of an Israeli company with approximately 20 years of operating experience is expected to strengthen BiomX’s Detection-Analysis-Response strategy through security systems, fire detection, access control, intrusion detection, building-control, electrical infrastructure and secure-site integration capabilities July 08, 2026 07:05 ET | Source: BiomX NETANYA, Israel, July 08, 2026 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
-
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
July 07, 2026 09:12 ET | Source: Alamar Biosciences, Inc. eMTBR-Tau offers a non-invasive, blood-based measurement of the tau tangle burden, the core pathology associated with disease progression and cognitive decline in Alzheimer’s disease Immunoassay for eMTBR-Tau is available in the NULISAseq™ Neuro 220 panel and as a single-plex assay through the Technology Access Program…
-
Medicine Beyond Borders: Zydus Hospital, Ahmedabad, Emerges as a Preferred Destination for International Patients
AHMEDABAD, India, July 7, 2026 /PRNewswire/ — Quality healthcare should never be a matter of geography or means, yet for patients in many parts of the world, it still is. As illnesses grow more complex and treatments advance, the gap between what is medically possible and what is locally accessible keeps widening for many. Patients travelling…
-
Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)
Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
World’s First International Patient Begins Treatment with Newly Approved Solid Tumor CAR-T Therapy at Jiahui International Cancer Center
SHANGHAI, July 6, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) has welcomed the world’s first international patient to begin treatment with Satri-cel, the world’s first approved CAR-T therapy for a solid tumor, marking a historic milestone in expanding global access to China’s latest oncology innovations. Josh, a 59-year-old patient from New Zealand with advanced…
-
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the…
-
STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication
SEOUL, South Korea, July 1, 2026 /PRNewswire/ — STARMED, a medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for a thyroid-specific indication (510(k) number: K252833). The clearance took effect on 26 May 2026. The company’s system may now…
-
Mark Leeds, D.O. PA Launches FloridaTaper.com, a Free Educational Resource on Benzodiazepine Tapering, Withdrawal, and BIND
The new website from Mark Leeds, D.O. PA offers more than 60 physician-written articles, with new articles published daily, for patients, families, and clinicians navigating slow benzodiazepine dose reductions. July 03, 2026 18:58 ET | Source: Mark Leeds, DO PA Fort Lauderdale, FL, July 03, 2026 (GLOBE NEWSWIRE) — Mark Leeds, D.O. PA, a Florida…
-
Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
LONDON, July 4, 2026 /PRNewswire/ — New research* commissioned by Velo highlights the lengths fans go to stay connected to the sports and teams they love, reinforcing the brand’s belief that fandom is an important form of self-expression. Building on this insight, Velo x McLaren Mastercard Formula 1® Team is relaunching Live Your Fandom for a second year —…
-
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
July 03, 2026 16:30 ET | Source: Teladoc Health, Inc. NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of…
-
NYSE Content Update: Mobility Global Marks First Day as Public Company
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 1, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on July 1st…
-
Jelly Force Male Enhancement Gummies Release Latest Formula for Men: JellyForce Unique Ingredient Profile Report
Pinellas Park, FL, July 02, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. JellyForce is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use, especially if currently taking prescription medications. JellyForce is a gummy dietary supplement formulated for men,…
-
Saroj Super Speciality Hospital Inaugurated in Nava Raipur
NAVA RAIPUR, India, July 2, 2026 /PRNewswire/ — Saroj Super Speciality Hospital, a unit of Ganesh Das Chawla Charitable Trust, formally inaugurated its new healthcare facility in Nava Raipur, Chhattisgarh, marking a significant step towards strengthening access to quality healthcare in the region. With a legacy of over 27 years in healthcare, Saroj Hospital has expanded…
-
GNI Group Completes Acquisition of AYUMI Pharmaceutical
TOKYO, July 01, 2026 (GLOBE NEWSWIRE) — GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi…
-
Bredehorst Clinic Medical Management, Germany’s Leading Healthcare Procurement Specialist, partners with Sigla
DÜSSELDORF, Germany, July 1, 2026 /PRNewswire/ — Düsseldorf – Sigla, a European private equity firm, is pleased to announce its investment in Bredehorst Clinic Medical Management GmbH (“BCMM” or “the Company”), Germany’s leading provider of tech-enabled procurement optimisation services for hospitals and care facilities. BCMM improves the purchasing of German healthcare providers, particularly hospitals, by…
-
Morepen Starts Commercial Supplies Under its Rs. 825 Crore CDMO Mandate; First Rs. 50 Crore Dispatch Already Completed in Q1FY2026-27
Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today issued an update on its recently announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation…
-
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
June 30, 2026 20:38 ET | Source: Mesoblast Limited NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing number from the U.S. Food and Drug Administration (FDA) and has requested a…
-
Basecamp Research brings EDEN’s antibiotic and vaccine design models to Claude Science
Scientists can now design potent antibiotics and rapidly prioritise vaccine targets through Claude Science, thanks to integration with Basecamp Research’s EDEN models. LONDON and CAMBRIDGE, Mass., June 30, 2026 /PRNewswire/ — Basecamp Research today announced that its antibiotic design and vaccine target prediction EDEN models are now available through Claude, including Claude Science, Anthropic’s AI…
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study Sanofi intends to submit the data to support a regulatory application in the…
-
GLOBAL MITOCHONDRIAL HEALTH SUMMIT 2026 POSITIONS MITOCHONDRIAL HEALTH AS THE FOUNDATION OF HEALTHSPAN
Sydney and Kuala Lumpur events unite world-leading experts as Mitochondrial Health gains recognition as a defining force in healthy ageing, and healthspan Researchers and clinicians identify Ubiquinol as a foundational nutrient in the Mitoceuticals category, supporting mitochondrial function throughout life, from preconception to healthy ageing SYDNEY, June 29, 2026 /PRNewswire/ — The inaugural global Mitochondrial Health…
-
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa Hopledo® is already approved and marketed in the United States as CREXONT®, providing established regulatory and commercial experience as the therapy advances toward European approval More than…
-
A ‘founding father of fitness’ – Les Mills Snr 1934 – 2026
AUCKLAND, New Zealand, June 29, 2026 /PRNewswire/ — We pay heartfelt tribute to our founder, Les Mills Snr, who passed away peacefully today, aged 91. A Kiwi icon, Les blazed a trail in sport, business, politics and life. Together with his wife Colleen, he created a fitness dynasty, first through the Les Mills New Zealand (LMNZ)…
-
TBoostExperts.com Announces Availability of 2026 Consumer Report on Testosterone Booster Supplements and Men’s Health Supplement Evaluation
NEW YORK,USA, June 27, 2026 (GLOBE NEWSWIRE) — TBoostExperts.com today announced the availability of its 2026 Consumer Research Report on testosterone booster supplements and men’s health supplement evaluation, a newly published educational resource developed to help adult consumers better understand how to review supplement labels, ingredient disclosures, dosage transparency, product claims, and company information before…
-
Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership
SILICON VALLEY, Calif., June 26, 2026 /PRNewswire/ — The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth Leadership Best Practices Recognition, honoring organizations that are setting new benchmarks for business leadership by tackling some of the world’s most critical challenges. This recognition celebrates enterprises that have successfully aligned…
-
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
LIKMEZ® (ATI-1501) commercial momentum building in U.S. market US$40 million NIAID award supporting VXV-01 advancement through Phase 1 HALIFAX, Nova Scotia, June 26, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and…
-
EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
GENEVA, June 27, 2026 /PRNewswire/ — Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026. Hearing loss is widely recognised as the largest modifiable risk…
-
As 'Substandard' Medicine Alerts Rise Sharply, Medkart Pharmacy Promotes Radical Transparency
With India’s drug regulator flagging a record number of medicines as ‘Not of Standard Quality’ in 2025, Medkart spotlights its Medkart Assured program – independent plant audits, dual third-party lab testing, and a pledge to publish its own quality data Ahmedabad, Gujarat, India Medicine quality has become one of the country’s most closely watched health…
-
Thought Leadership & Innovation Foundation Founder Bill Oldham Launches New Book: Beyond Better Data: What Actually Changes Health Care?
MCLEAN, Va., June 26, 2026 (GLOBE NEWSWIRE) — The Thought Leadership & Innovation Foundation (TLI) proudly announces the release of Beyond Better Data: What Actually Changes Health Care? a new book by Founder and Chairman Bill Oldham that brings together decades of experience in innovation, leadership, healthcare transformation, and the practical application of emerging technologies to…
-
Rare Neuro Emergency after Spinal Tumor Surgery Turns Critical, Ends in Successful Recovery at Zydus Hospital, Ahmedabad
Mother of two, saved after a whirlwind of physical turmoil AHMEDABAD, India, June 26, 2026 /PRNewswire/ — A 35-year-old woman, mother of one, had persistent lower back pain for a very long time. However, in the second pregnancy the pain became relatively severe where even doctors were unable to administer spinal anaesthesia. She delivered a healthy…
-
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) — Commure, a leading healthcare technology company, today announced it has been named “Overall NLP Company of the Year” in the 2026 AI Breakthrough Awards. The annual awards program recognizes the world’s most innovative companies, technologies, and products in artificial intelligence. Selected from more than 5,000 nominations…
-
Doctors at HCMCT Manipal Hospital Dwarka perform a life-saving heart bypass and robotic lung cancer surgery in a single session
NEW DELHI, June 25, 2026 /PRNewswire/ — Doctors at HCMCT Manipal Hospital Dwarka successfully performed a rare life-saving procedure on a 66-year-old man diagnosed with both coronary artery disease and lung cancer. While being examined for the cancer, the patient reported constant breathlessness and was found to have severe blockages in the arteries, along with cancer…
-
The Developing Doctor Launches CME-Accredited Course to Enhance Physician Wellbeing
Iowa City, IOWA, June 24, 2026 (GLOBE NEWSWIRE) — The Developing Doctor has unveiled its latest self-paced course, “Mastery & Wellness: How to Thrive as a Physician,” now approved for 12 physician CME credits. This course is jointly provided with the Postgraduate Institute for Medicine (PIM), making it eligible for reimbursement through most institutional CME…
-
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
YOKOHAMA, Japan, June 24, 2026 /PRNewswire/ — REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal®, for which the company holds exclusive commercialization rights in Japan. The application seeks approval for the use of Stemchymal® to suppress the progression of ataxia in…
-
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
– First patient dosed in a Phase 1 study evaluating ZM008, an anti-LLT1 mAb, in combination with LOQTORZI, a next-generation PD-1 inhibitor – June 23, 2026 14:00 ET | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. (“Zumutor”), an immuno-oncology biotech…
-
TraceLink Named Fortress Cybersecurity Awards Finalist for Enabling the Transformation to a Secure, Auditable Agentic Supply Chain Operating Model
OPUS Platform and OPUS Agents recognized for enabling no-code AI agents to operate as permissioned, traceable participants in regulated pharmaceutical supply chain operations Summary TraceLink has been named a finalist in the 2026 Fortress Cybersecurity Awards for OPUS and OPUS Agents. The recognition highlights TraceLink’s ability to support agentic supply chain operations in one of…
-
Dyne Therapeutics Appoints Barry Greene to Board of Directors
June 22, 2026 16:10 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., June 22, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment of Barry Greene to its Board of Directors. Mr. Greene brings more…
-
Texas A&M Study Highlights Pictor PictVet® as a Promising New Tool for Non-Invasive Beef Cattle Health Monitoring
Independent peer-reviewed research published in Frontiers in Veterinary Science reports strong assay performance in a proof-of-concept evaluation using bovine nasopharyngeal swab samples CARLSBAD, Calif., June 22, 2026 /PRNewswire/ — Pictor Holdings Inc., a global targeted proteomic platform company, today highlighted the publication of an independent peer-reviewed study conducted by researchers at Texas A&M University and published…
-
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK…
-
Zydus Hospital, Ahmedabad sets a new dimension in Alzheimer testing
A simple blood test can now detect AD early, boosting quality of life AHMEDABAD, India, June 19, 2026 /PRNewswire/ — As people grow older, changes occur in all parts of the body, including the brain. Forgetfulness can be a normal part of aging. Alzheimer’s disease (AD) is the most common type of dementia and can be…
-
JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. JellyFil is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
Pope Leo XIV embraces paediatric patients at CNAO in Pavia
PAVIA, Italy, June 20, 2026 /PRNewswire/ — The National Center for Oncological Hadrontherapy (CNAO) served as the first stop today during Pope Leo XIV’s pastoral visit to the city of Pavia. His choice to begin his journey at this center reflects a profound commitment to fostering meaningful dialogue between advanced scientific progress and the alleviation…
-
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
AURORA, CO, June 19, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. BreathEaseX is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
NCL’s Nanha Sa Dil – Transforming Rural Child Heart Care in India
The story of a Farmer’s daughter from Singrauli, MP SINGRAULI, India, June 19, 2026 /PRNewswire/ — Six-year-old Pranjali Prajapati lives in Sarai village of Singrauli district, Madhya Pradesh. Her family depends on farming for a living. With a monthly income of about ₹5,000–6,000, life has never been easy. For a long time, Pranjali would tire…
-
Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes
LAS VEGAS, June 18, 2026 (GLOBE NEWSWIRE) — Desert Hope Treatment Center, a leading addiction treatment center in Las Vegas, has introduced its First Responder Lifeline Program, designed specifically for law enforcement officers, firefighters, EMTs, dispatchers, corrections officers, and other public safety professionals. The program was developed in collaboration with public safety leaders, including representatives…
-
Frost & Sullivan Identifies Virtual Healthcare Assistants as a Transformational Force in Healthcare Delivery
New analysis highlights significant growth opportunities in patient- and clinician-facing AI assistants as healthcare organizations seek to improve efficiency, patient engagement, and care outcomes LONDON, June 18, 2026 /PRNewswire/ — Frost & Sullivan’s latest analysis, Innovations and Growth Opportunities in Virtual Healthcare Assistants, finds that artificial intelligence-powered virtual healthcare assistants are poised to transform healthcare delivery…
-
Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470
Press Release Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Exclusive licensee for China, Ocumension, received positive pre-submission regulatory feedback from the Chinese Center for Drug Evaluation (CDE) for NCX 470 Based on this feedback, Ocumension intends to proceed with the New Drug Application (NDA) submission in China Submission…
-
ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units
JENA, Germany, June 17, 2026 /PRNewswire/ — ZEISS Medical Technology announced today that the company held a signing ceremony with the Aier Eye Hospital Group, entering into a strategic agreement for the purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers across multiple Aier Eye Hospital locations. The signing ceremony was conducted on June…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
APAC healthcare systems face growing strain as rising patient expectations collide with stretched clinical workforce – Bain & Company survey
95% of consumers want a single touchpoint to manage their healthcare 84% of consumers expect greater convenience from healthcare system Three in four consumers comfortable with AI-enabled healthcare apps One in five doctors actively considering leaving their current employer due to burnout SINGAPORE, June 17, 2026 /PRNewswire/ — Asia-Pacific healthcare systems are facing growing strain…
-
Weston Family Foundation invests an additional $37 million to safeguard one of Canada’s most ecologically valuable and threatened ecosystems
The conservation initiative brings together Indigenous communities, ranchers, and conservation organizations to protect Canada’s critical prairie grasslands June 16, 2026 06:00 ET | Source: Weston Family Foundation TORONTO, June 16, 2026 (GLOBE NEWSWIRE) — The Weston Family Foundation just announced an additional $37 million in funding through the Weston Family Prairie Grasslands Initiative, strengthening and…
-
Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World’s Most Pressing Challenges
SILICON VALLEY, Calif., June 15, 2026 /PRNewswire/ — The Frost & Sullivan Institute is pleased to present the 2026 Visionary Growth Leadership Best Practices Recognition, celebrating leading enterprises that are redefining the role of business in addressing the world’s most urgent challenges. This recognition honors organizations that have embedded innovation, measurable impact, and long-term sustainability…
-
Maiva Pharma Inaugurates New State-of-the-Art Sterile Injectable Manufacturing Facility at Shoolagiri, India
Six manufacturing lines to enable production of diverse sterile injectable formats, from vials and pre-filled syringes to cartridges, suspensions and lyophilized formulations Bengaluru, Karnataka, India Maiva Pharma, a leading global Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) specialising in sterile injectables, today inaugurated its new manufacturing facility at Shoolagiri, Tamil Nadu,…
-
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
June 15, 2026 08:05 ET | Source: Polyrizon Ltd. New performance and characterization study in collaboration with leading European medical center marks a critical milestone in the validation of the NASARIX™ allergy blocker’s protective barrier function Raanana, Israel, June 15, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech…
-
UFC GYM® India Announces the Grand Opening of Its Second Premium Fitness Club in Jaipur
This 20,000 sq. ft. facility will redefine fitness standards in Jagatpura, which is the fastest-growing urban hub in Jaipur JAIPUR, India, June 14, 2026 /PRNewswire/ — UFC GYM®, the official brand extension of the UFC®, proudly announces the launch of its second premium fitness destination in Jaipur which is located at Jagatpura. The first location opened…
-
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
– Verekitug, administered once every three months, led to clinically meaningful improvements in nasal polyp score (NPS) in approximately 80% of participants – – Majority of verekitug-treated participants experienced clinically meaningful improvements across key secondary endpoints, including 72% in nasal congestion and 83% in CRSwNP total symptom score – WALTHAM, Mass., June 14, 2026 (GLOBE…
-
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS); new data from the…
-
QNET DENIES ANY ASSOCIATION WITH IGNITE
HYDERABAD, India, June 13, 2026 /PRNewswire/ — QNET has taken note of recent media reports published in Telangana concerning the alleged activities of an entity operating under the name IGNITE, as well as references that seek to associate those activities with QNET and its franchisee in India, Vihaan Direct Selling (India) Pvt. Ltd. Given the…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions
WASHINGTON, June 12, 2026 /PRNewswire/ — ELIQUENT Life Sciences (“ELIQUENT”) today announced the June 1 go-live of Veeva Safety Suite at UCB. As one of the first organizations to adopt the complete suite, UCB is unifying its global safety operations in a transformation delivered through a strategic collaboration between Veeva, ELIQUENT, Pinnaxis, and Daelight Solutions.…
-
Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health
Milestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals. NORWALK, Conn., June 11, 2026 /PRNewswire/ — Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congratulates its portfolio company Rejuvenate Bio on the successful close of a $6 million financing round and…
-
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, June 10, 2026 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), announced today that its shareholders voted in favour of all items of business brought before them at the Company’s annual and…
-
Published Study Shows Clinically Significant Energy, Performance, and Metabolic Benefits of FutureCeuticals’ Caffinity™
MOMENCE, Ill., June 10, 2026 /PRNewswire/ — FutureCeuticals, Inc. is pleased to announce the peer-reviewed publication of clinical research demonstrating unique energy, performance, and metabolic benefits of Caffinity™, a proprietary ingredient derived from the Arabica coffee cherry (bean and fruit). This study, conducted by recognized experts in energy metabolism at the University of Exeter (UK), establishes…
-
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
June 09, 2026 19:00 ET | Source: ARCpoint Inc. GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall’s appointment remains subject to acceptance…
-
Huawei Launches the “AHEAD” Program to Build a New Ecosystem for Mutual Benefits in Education and Healthcare
SHENZHEN, China, June 9, 2026 /PRNewswire/ — The 2026 Global Education & Healthcare Partners Convention, convened under the theme “Together, Enabling Intelligent-led Education & Healthcare,” successfully concluded in China. The event drew over 500 industry customers and partners across more than 40 countries and regions. At the event, Huawei unveiled the Alliance on Healthcare &…
-
Not Just Pharmacy: How Medkart is Building India's Smartest Generic Medicine App
Ahmedabad, Gujarat, India India’s pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the world’s largest medicine markets, millions of Indian families continue to struggle with the high cost of treatment. Studies show that over 50% of healthcare expenses in India are still paid out-of-pocket, leaving many to either delay care…
-
Medkart Champions Generic Drug Quality Amid Rising Consumer Concerns
Ahmedabad, Gujarat, India With growing scrutiny around the quality and reliability of generic medicines in India, Medkart, Gujarat’s largest generic-first pharmacy chain, is stepping forward to assure patients that affordability does not mean compromise. In response to increasing consumer concerns, the company has reinforced its Medkart Assured program—rooted in audit-based sourcing, Schedule M compliance, and…
-
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas June 07, 2026 19:41 ET | Source: GNI Group Co., Ltd. TOKYO, June 07, 2026 (GLOBE NEWSWIRE) — GNI Group Co., Ltd. (TSE: 2160) today announced that it has entered into an agreement to acquire 100% of the shares…
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
IFQM Symposium 2025 Concludes with a Call for Quality & Innovation to Make India Globally Competitive
New Delhi, Delhi, India India is at the cusp of developing and making products for the world, with quality that is of international standards, especially in the electronics and semiconductor industry, and MSMEs and startups have huge potential. It is not a distant ambition but a fast-emerging reality, but does India have the hunger to…
-
This Pharmacy Chain is Saving India INR 300 Cr a Year – And You've Probably Never Heard of It
In India’s complex and expensive healthcare ecosystem, where sufferers still consume a significant portion of their income on pharmaceuticals, a quiet transformation is ongoing. While digital health startups often lead headlines, one drugstore chain is leading a hidden but impactful transformation. Medkart, based in Gujarat and focused solely on generic medicines, is helping Indian households…
-
Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews
Editorial note: This article is an independent informational evaluation of publicly available product information. It is not medical advice, not a diagnosis or treatment recommendation, and not an endorsement of any brand. Dietary supplements are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, including menopause. Statements have not…
-
SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects
Mumbai, Maharashtra, India Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1. Despite advances in medical care, CHD continues to be a leading cause of infant and child mortality, highlighting the need for…
-
MrMed Expands Its Reach with New Bengaluru Cold-Chain Hub to Improve Access to GLP-1 and Critical Care Medicines
MrMed, India’s largest online super-specialty pharmacy, has opened a state-of-the-art cold-chain distribution hub in Bengaluru. The new facility strengthens the company’s ability to deliver temperature-sensitive medicines especially GLP-1 therapies quickly and safely across South India. MrMed Bengaluru Hub As diabetes and obesity continue to rise at an alarming rate, with over 100 million people in…
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
-
Quantinuum Announces Closing of Upsized Initial Public Offering
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public offering price of $60.00 per share. All of the shares were offered by Quantinuum. The aggregate gross proceeds from the…
-
Zuellig Pharma Unveils State-of-the-art Clinical Trial Support Innovation Center in South Korea to Support both Domestic and Global Clinical Research Needs
Gyeonggi-Do, South Korea Zuellig Pharma, a leading healthcare solutions company in Asia, today announced the grand opening of its new state-of-the-art Clinical Trial Support (CTS) Innovation Center in South Korea. The opening of this facility underscores Zuellig Pharma’s continued investment and commitment to advancing healthcare, reinforcing its position as a trusted regional partner in driving…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.